Evidence map›Paper›PMID 24876626›Full record

ArticleJournal of diabetes science and technology2014

Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials.

Oliver Schnell, Markolf Hanefeld, Louis Monnier

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review of methods for detecting glycemic disorders.Diabetes research and clinical practice · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Oliver SchnellForschergruppe Diabetes e.V. at the Helmholtz Center, Neuherberg, Germany Oliver.Schnell@lrz.uni-muenchen.de.
Markolf HanefeldStudy Centre Professor Hanefeld, GWT-TUD GmbH, Dresden, Germany.
Louis MonnierInstitute of Clinical Research, University Montpellier I, Laboratoire de Nutrition Humaine, Institut Universitaire de Recherche Clinique, France.
GWT-TUD (Germany) · DEHelmholtz Zentrum München · DEInstitut Universitaire de Recherche Clinique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence for the value of self-monitoring of blood glucose (SMBG) with regard to the achievement of treatment targets, detection of postprandial glucose excursions, and minimization of glycemic variability is increasing. In large clinical trials, SMBG is a key component for the optimization of diabetes treatment in insulin-treated diabetes. It also plays an essential role in outcome studies. However, details of SMBG use in both the methods and results sections of clinical articles are frequently scarce. Also, a discussion of the SMBG data and its impact on insulin therapy is valuable. In the recently completed Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial, SMBG was described in detail and insulin titration was largely driven by SMBG. Both aspects largely contributed to the fact that near-normal control was achieved over a long-term period.

Indexed as

Blood Glucose Self-MonitoringResearch DesignBiomarkersBlood GlucoseDiabetes Mellitus, Type 2Endpoint DeterminationGlycated HemoglobinHumansHypoglycemic AgentsInsulin GlarginePractice Guidelines as TopicPredictive Value of TestsRandomized Controlled Trials as TopicTreatment OutcomeBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin Glargineblood glucosediabetesself-monitoringSMBG

Identifiers

PMID24876626
PMCPMC4455440
OpenAlexW1975042678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.